Genome editing to treat human retinal degeneration

(Mary Ann Liebert, Inc./Genetic Engineering News) Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety concerns, and strategies to overcome these challenges